Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.31 +0.01 (+3.33%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) FCF Margin (2011 - 2026)

Updated

Vistagen Therapeutics (VTGN) recorded FCF Margin of -996.41% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 6754.00 percentage points from -7750.41% a year earlier and up 2487.46 percentage points from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) FCF Margin (2011 - 2026) Analysis & Trends

On a TTM basis, Vistagen Therapeutics' FCF Margin came in at -2493.33% as of Jun 30, 2026, up 5277.57 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -5235.30%, up 3426.63 percentage points from FY2025.

  • Annual FCF Margin has a five-year change of -4101.86 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, FCF Margin came in at -8661.93% in FY2025 (-6235.90 pp), -2426.03% in FY2024 (+19707.89 pp), -22133.92% in FY2023 (-18053.08 pp) and -4080.84% in FY2022 (-2947.39 pp).
  • The fiscal Q1 2027 figure is the highest quarterly FCF Margin since fiscal Q2 2021.
  • On a year-over-year basis, FCF Margin rose in three of the last six quarters, with an average year-over-year change of +672.56 percentage points.
  • Peak year-over-year performance for FCF Margin in the last five years was a gain of 35031.01 percentage points in fiscal Q4 2023, against a drop of 38256.15 percentage points in fiscal Q4 2022 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -3483.87% (Q4 2026), -5827.39% (Q3 2026) and -5356.20% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.82%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 18.33%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 26.96%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 43.05%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 34.72%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.70%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 44.00%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 30.39%
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - -996.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -996.41%
Mar 31, 2026 -3,483.87%
Dec 31, 2025 -5,827.39%
Sep 30, 2025 -5,356.20%
Jun 30, 2025 -7,750.41%
Dec 31, 2024 -4,393.16%
Sep 30, 2024 -5,981.97%
Jun 30, 2024 -12,989.29%
Mar 31, 2024 -4,239.63%
Dec 31, 2023 -1,162.77%
Sep 30, 2023 -2,063.33%
Jun 30, 2023 -3,945.50%
Mar 31, 2023 -4,425.91%
Dec 31, 2022 -5,525.44%
Sep 30, 2022 -1,832.61%
Jun 30, 2022 -5,205.87%
Mar 31, 2022 -39,456.92%
Dec 31, 2021 -3,364.64%
Sep 30, 2021 -3,212.32%
Jun 30, 2021 -1,786.10%
API Access

Vistagen Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEY